Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
In the latest session, FibroBiologics Inc (NASDAQ: FBLG) closed at $0.61 down -7.48% from its previous closing price of $0.66. In other words, the price has decreased by -$7.48 from its previous closing price. On the day, 0.95 million shares were traded. FBLG stock price reached its highest trading level at $0.6501 during the session, while it also had its lowest trading level at $0.6.
Ratios:
For a deeper understanding of FibroBiologics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.14 and its Current Ratio is at 1.14. In the meantime, Its Debt-to-Equity ratio is 3.03 whereas as Long-Term Debt/Eq ratio is at 0.37.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on December 12, 2024, initiated with a Buy rating and assigned the stock a target price of $12.
On October 30, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $12.
On September 24, 2024, Maxim Group started tracking the stock assigning a Buy rating and target price of $12.Maxim Group initiated its Buy rating on September 24, 2024, with a $12 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 27 ’25 when Khoja Hamid bought 20,000 shares for $0.84 per share. The transaction valued at 16,800 led to the insider holds 31,250 shares of the business.
O’HEERON PETE bought 8,500 shares of FBLG for $16,269 on Aug 12 ’24. The Chief Executive Officer now owns 6,056,647 shares after completing the transaction at $1.91 per share. On Aug 12 ’24, another insider, Khoja Hamid, who serves as the Chief Scientific Officer of the company, bought 10,000 shares for $1.90 each. As a result, the insider paid 19,000 and bolstered with 11,250 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FBLG now has a Market Capitalization of 25123170 and an Enterprise Value of 21670564.
Stock Price History:
The Beta on a monthly basis for FBLG is -0.63, which has changed by -0.8834933 over the last 52 weeks, in comparison to a change of 0.15366066 over the same period for the S&P500. Over the past 52 weeks, FBLG has reached a high of $5.54, while it has fallen to a 52-week low of $0.58. The 50-Day Moving Average of the stock is -18.29%, while the 200-Day Moving Average is calculated to be -60.81%.
Shares Statistics:
For the past three months, FBLG has traded an average of 375.04K shares per day and 526620 over the past ten days. A total of 37.74M shares are outstanding, with a floating share count of 29.66M. Insiders hold about 28.35% of the company’s shares, while institutions hold 15.45% stake in the company. Shares short for FBLG as of 1752537600 were 730581 with a Short Ratio of 1.95, compared to 1749772800 on 1347117. Therefore, it implies a Short% of Shares Outstanding of 730581 and a Short% of Float of 2.07.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
